NeuroScientific Biopharmaceuticals Ltd. advised the appointment of Abby Macnish as Company Secretary, and responsible for all Company Secretary responsibilities for NSB, following a period of concurrent management and handover with former Company Secretary Thomas Spencer, and effective 20 April 2020. Abby holds degrees in Commerce and Science, is a CFA charterholder and has over 15 years' experience in investments and equity markets. Former co-Company Secretary Thomas Spencer has resigned, effective 20 April 2020.